GSK faces setback over Zantac lawsuit; TB treatment on video

Taking stock of the drug industry, from the lab to the medicine chest

March 24, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Drew Angerer/Getty Images STAT+ | California judge deals GSK a setback as first Zantac lawsuit will now go to trial Thousands of lawsuits filed against GSK and other Zantac manufacturers claim the widely used medicine causes different types of cancer. By Ed Silverman Directly observed therapy for TB treatment, via video, gets CDC nod A health care worker watching, via a video call, as a person with tuberculosis swallows their pills, is as effective as in-person observation, the CDC says. By Helen Branswell STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser